Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pembrolizumab in Chemo-Resistant Gestational Trophoblastic Neoplasia
NCT04303884Phase 2Unknown
- Sponsor
- CHA University
- Start
- Jun 2020
- Primary completion
- May 2022
- Modality
- Immune Checkpoint Inhibitors, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of pembrolizumab in gestational trophoblastic neoplasia (GTN), sponsored by CHA University. Status: unknown.
02
Drugs
03
Conditions
gestational trophoblastic neoplasia (GTN)
Beyond the preview
Go deeper on NCT04303884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04303884.